Immuneel Therapeutics Private
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $26M
Investors
- 7
About Immuneel Therapeutics Private
Based in India and founded in 2018, Immuneel Therapeutics Private Limited, operates as a biotech company, providing cell therapy and personalized immunotherapy for cancer patients. The company was founded by Biocon founder and chairperson Kiran Mazumdar-Shaw, Dr.S. oncologist and author of the Pulitzer Prize-winning novel, and Kush Parmar. Immuneel Therapeutics offers access to Chimeric Antigen Receptor T cell therapy (CAR-T), name named IMAGINE, and other cellular immunotherapies for the management and treatment of cancers. Immuneel’s IMAGINE trial for CD19 CAR-T (IMN-003A) for B cell malignancies (Leukemia & Lymphoma) is ongoing in India. Immuneel has exclusive rights to ARI-0001/IMN-003A (a CD-19 CAR-T cell therapy) from Hospital Clínic de Barcelona and Institut d’Investigacions Biomèdiques August Pi i Sunyer in Spain to develop, manufacture and commercialize in India via technology transfer.
Who invested in Immuneel Therapeutics Private
7 investors across 3 rounds
See all investors in Immuneel Therapeutics Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Immuneel Therapeutics Private
Who invested in Immuneel Therapeutics Private?
Immuneel Therapeutics Private has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Immuneel Therapeutics Private raised?
Immuneel Therapeutics Private has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Immuneel Therapeutics Private last raise money?
Immuneel Therapeutics Private's most recent round on record is a Series B, in Jun 2026.
What does Immuneel Therapeutics Private do?
Based in India and founded in 2018, Immuneel Therapeutics Private Limited, operates as a biotech company, providing cell therapy and personalized immunotherapy for cancer patients.
Where is Immuneel Therapeutics Private headquartered?
Immuneel Therapeutics Private is headquartered in Bangalore, India.
Which VCs invest in companies like Immuneel Therapeutics Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Immuneel Therapeutics Private's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Immuneel Therapeutics Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.